Gene Change Disrupts Kidney Protein in Roundworms

Rutgers researchers used a gene-editing tool to study a suspected kidney disease mutation in C. elegans worms.

Updated on Nov. 3, 2026 in Life Sciences

Gene Change Disrupts Kidney Protein in Roundworms

Researchers at Rutgers University altered one small part of the DNA of the roundworm C. elegans to study a genetic change linked to kidney disease. The findings were published in the journal Genetics.

Why it matters

The study examines what a suspected disease-related genetic change actually does at the cellular level. Understanding how the altered protein behaves may help clarify the biology behind polycystic kidney disease.

The study used 60 males in each group and found the altered polycystin-2 protein at about 15% of normal levels in the nerve cell body, compared with normal function in controls. Researchers have not yet determined whether these laboratory results apply to human kidney disease.

The players

Rutgers University

A public research university in New Jersey where the study on polycystin-2 in C. elegans was conducted.

The details

Using CRISPR, a gene-editing tool, the team made a precise change to the worm's polycystin-2 gene. They inserted both altered and healthy protein versions into the same worm and tracked them with different fluorescent dyes to observe where each one traveled.

Nov. 3, 2026: Article describing the Rutgers study findings published

The Big Picture

Caenorhabditis elegans has long served as a model organism for dissecting polycystin signaling in cilia, and this study uses that system to test a suspected disease mutation directly. The work builds on the established role of PKD2 defects in roughly one in seven or eight cases of autosomal dominant polycystic kidney disease.

Findings from model organisms like C. elegans can help guide which genetic changes deserve closer study in human kidney disease research. For people affected by ADPKD, which affects roughly 1 in 400 to 1 in 1,000 people, clearer biology may eventually inform future treatment development.

The takeaway

Basic research using simple organisms can reveal how disease-linked mutations disrupt cell function before any treatment is considered. Readers interested in kidney health can track how such laboratory findings move toward human studies.